MeridianRX aces URAC accreditation criteria

MeridianRX received a 100 percent score and met all seven optional leading indicators during its URAC accreditation. | MeridianRX

MeridianRX said it earned a 100 percent score and met all seven optional leading indicators on its way to a Utilization Review Accreditation Commission (URAC) accreditation for Pharmacy Benefit Management, the company said on Thursday.

The leading indicators for URAC are nonweighted, optional and meant to highlight effective practices that are not adopted by the health care industry.

Rene Acker, chief operating officer of MeridianRX, said the company was very proud to earn the score, and that it is a “testament” to employee dedication and “commitment to transparency, flexibility and innovation.”

"Meeting these seven indicators shows our innovation and how we differentiate ourselves from other pharmacy benefit management companies," Acker said. "We go above and beyond the standard in our field to ensure our members and clients receive the best care possible."

URAC, a nonprofit, independent health care accrediting organization, uses standards that are circulated widely and are beta-tested and available for public comment before the accreditation process begins.

"MeridianRx should be commended for meeting strict quality standards," URAC President and CEO Kylanne Green said. "It is critically important for health care organizations to make a commitment to quality and accountability. URAC accreditation is a demonstration of that commitment."

MeridianRX -- a full-service, family-owned pharmacy -- has clients that include small, medium and large employer groups, unions, health plans and other public entities.